Navigation Links
Calcitriol [Vitamin D] with combination of painkillers for cancer treatment

Professor David Feldman and his colleagues from the Stanford University School of Medicine have reported the results of their study in the journal Cancer Research. The result of the study has found that //high doses of Vitamin D with pain killers were found to reduce the growth of cancer in patients with prostate cancer. The study result say that the combination of these two drugs reduces the growth of prostate cancer by 70 percent.

Due to very impressive results, the research team has started a clinical trial to see if the approach also works in men. "There is great enhancement when the drugs are given together, using what we think is a safe dose in humans," Feldman said in a statement. "It‘s hard to make an exact comparison, as we are talking about cells in a dish and not a person." "We don‘t want the patient to think that if they take over-the-counter vitamin D, it will work in the same way," Feldman said.

The research team is testing the effect of Calcitriol, which is a form of Vitamin D that is efficiently metabolized by the body and more effective than other Vitamin D pills and fortified milk. The researchers wanted to exploit the earlier research results of Calcitriol and pain killers in the treatment of cancer, the workers wanted to test the synergistic effect of combining both the drugs for cancer treatment.

In a tissue culture study involving tumor cells, the administration of calcitriol reduced the prostate cell growth by 25 percent and combining painkillers like ibuprofen and naproxen with calcitriol killed 70 percent of the prostate cancer cells.
'"/>




Page: 1

Related medicine news :

1. Will The Combination Of Calcitriol and Docetaxel Work ?
2. The bad combination
3. Warding off symptoms of premenstrual syndrome by combination therapy
4. Cholesterol can be lowered using combination of Soy Proteins and Sterols
5. Nanocells cancer combination therapy acts as chemotherapy as well as anti-angiogenic drug
6. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
7. Eloxatin combination reduces bowel cancer recurrences
8. Death from heart attack can be reduced by new drug combination
9. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
10. More effective Antiretroviral HIV drug combination
11. Salmeterol - to be used in combination & only when required
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2017)... (PRWEB) , ... April 30, 2017 , ... PracticeMatch, a ... increase in projected attendance for this year’s physician career fairs, with this year’s RSVPs ... complete schedule for the 2017 calendar year of national physician career fairs is located ...
(Date:4/29/2017)... S.C. (PRWEB) , ... April ... ... Southeast’s leading software and web development company, today announced the launch of ... DonorBridge is a solution combining decades of software innovation and industry expertise ...
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set of dynamic transitions ... the next without having to set a single keyframe in Final Cut Pro ... video production. , TransDark features dynamic transitions that momentarily splits the RGB layers of ...
(Date:4/29/2017)... ... April 29, 2017 , ... Sterling Global Products ... fine retailers selling biodegradable, hanging flushable wipes dispensers and/or 42 count refill packs ... in San Antonio, Texas, operates more than 350 stores throughout Texas and expanding ...
(Date:4/29/2017)... ... April 29, 2017 , ... ... and recognize the positive impact veterinarians have on animal health and welfare as ... Organization for Animal Health (OIE) choose a theme each year and this year ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... Halo Labs announces the launch of a ... called the Horizon at PEGS 2017 in ... analyzes sub visible particulate matter in biopharmaceutical samples to ... early as candidate selection and pre-formulation. Halo ... organization Elion Labs for system validation. "We ...
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)... 2017   ZappRx, Inc ., a digital health company ... today announced it closed $25 million in Series B funding ... based in Seattle that is part ... The Series B round included participation from SR One ... GV (formerly Google Ventures). As part of the ...
Breaking Medicine Technology: